228 related articles for article (PubMed ID: 9252722)
1. Comparison of the long-term results of brachytherapy for T1-2N0 oral tongue cancer treated with Ir-192 and Ra-226.
Yamazaki H; Inoue T; Koizumi M; Yoshida K; Kagawa K; Shiomi H; Nose T; Tanaka E; Teshima T; Nakamura H; Shimizutani K; Furukawa S; Fuchihata H; Inoue T
Anticancer Res; 1997; 17(4A):2819-22. PubMed ID: 9252722
[TBL] [Abstract][Full Text] [Related]
2. [Postoperative recurrence-related factors of 125 patients with cT1-2N0 squamous cell carcinoma of the oral tongue].
Han JM; Wu GH; Zeng ZY; Chen FJ; Chen WK; Li H; Song M; Sun CZ
Ai Zheng; 2007 Jun; 26(6):661-5. PubMed ID: 17562277
[TBL] [Abstract][Full Text] [Related]
3. Comparison of three major radioactive sources for brachytherapy used in the treatment of node negative T1-T3 oral tongue cancer: influence of age on outcome.
Yamazaki H; Inoue T; Yoshida K; Yoshioka Y; Furukawa S; Kakimoto N; Shimizutani K
Anticancer Res; 2007; 27(1B):491-7. PubMed ID: 17348432
[TBL] [Abstract][Full Text] [Related]
4. The importance of interstitial radiotherapy in the treatment of the base of tongue tumors: a retrospective analysis.
Takácsi-Nagy Z; Oberna F; Polgár C; Somogyi A; Major T; Németh G
Neoplasma; 2001; 48(1):76-81. PubMed ID: 11327543
[TBL] [Abstract][Full Text] [Related]
5. Age as a prognostic factor for late local recurrence of early tongue cancer treated with brachytherapy.
Yamazaki H; Inoue T; Koizumi M; Yoshida K; Kagawa K; Shiomi H; Imai A; Tanaka E; Teshima T; Nakamura H; Shimizutani K; Furukawa S; Fuchihata H; Inoue T
Anticancer Res; 1997; 17(6D):4709-12. PubMed ID: 9494593
[TBL] [Abstract][Full Text] [Related]
6. Tongue cancer treated with brachytherapy: is thickness of tongue cancer a prognostic factor for regional control?
Yamazaki H; Inoue T; Teshima T; Tanaka E; Koizumi M; Kagawa K; Imai A; Yoshida K; Shiomi H; Shimizutani K; Furukawa S; Fuchihata H; Nakamura H; Inoue T
Anticancer Res; 1998; 18(2B):1261-5. PubMed ID: 9615798
[TBL] [Abstract][Full Text] [Related]
7. Treatment of early tongue carcinoma with brachytherapy: results over a 25-year period.
Urashima Y; Nakamura K; Shioyama Y; Nomoto S; Ohga S; Toba T; Yoshitake T; Chikui T; Kawazu T; Jingu K; Terashima H; Honda H
Anticancer Res; 2007; 27(5B):3519-23. PubMed ID: 17972511
[TBL] [Abstract][Full Text] [Related]
8. [Clinical dosimetry in radium 226 and iridium 192 interstitial therapy of oral tongue cancer (author's transl)].
Baroncelli G; Feroldi P; Frata P
Radiol Med; 1980 Nov; 66(11):819-26. PubMed ID: 7221048
[TBL] [Abstract][Full Text] [Related]
9. Base-of-tongue cancer: survival, function, and quality of life after external-beam irradiation and brachytherapy.
Robertson ML; Gleich LL; Barrett WL; Gluckman JL
Laryngoscope; 2001 Aug; 111(8):1362-5. PubMed ID: 11568569
[TBL] [Abstract][Full Text] [Related]
10. Brachytherapy in the treatment of Stage IV carcinoma of the base of tongue.
Cano ER; Johnson JT; Carrau R; Agarwala S; Flickinger J; Quader M
Brachytherapy; 2004; 3(1):41-8. PubMed ID: 15110313
[TBL] [Abstract][Full Text] [Related]
11. A comparison of brachytherapy and surgery for the treatment of stage I-II squamous cell carcinoma of the tongue.
Umeda M; Komatsubara H; Ojima Y; Minamikawa T; Shibuya Y; Yokoo S; Ishii J; Komori T
Int J Oral Maxillofac Surg; 2005 Oct; 34(7):739-44. PubMed ID: 15921890
[TBL] [Abstract][Full Text] [Related]
12. [Time factor and curietherapy: the example of epidermoid carcinoma of the mobile tongue].
Mazeron JJ; Mornex F
Bull Cancer Radiother; 1990; 77(1):15-22. PubMed ID: 8703538
[TBL] [Abstract][Full Text] [Related]
13. Exclusive low-dose-rate brachytherapy in 279 patients with T2N0 mobile tongue carcinoma.
Bourgier C; Coche-Déquéant B; Fournier C; Castelain B; Prévost B; Lefebvre JL; Lartigau E
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):434-40. PubMed ID: 16168836
[TBL] [Abstract][Full Text] [Related]
14. Prediction of lymphatic metastasis based on gene expression profile analysis after brachytherapy for early-stage oral tongue carcinoma.
Watanabe H; Mogushi K; Miura M; Yoshimura R; Kurabayashi T; Shibuya H; Tanaka H; Noda S; Iwakawa M; Imai T
Radiother Oncol; 2008 May; 87(2):237-42. PubMed ID: 18222011
[TBL] [Abstract][Full Text] [Related]
15. Definitive radiotherapy with interstitial implant boost for squamous cell carcinoma of the tongue base.
Karakoyun-Celik O; Norris CM; Tishler R; Mahadevan A; Clark JR; Goldberg S; Devlin P; Busse PM
Head Neck; 2005 May; 27(5):353-61. PubMed ID: 15726587
[TBL] [Abstract][Full Text] [Related]
16. [Brachytherapy in the management of the initial stage of the mobile tongue carcinoma].
Bolner A; Campolongo F; Segatta P; Fellin G; Bauer M; Nocini PF
Acta Otorhinolaryngol Ital; 1999 Apr; 19(2):80-6. PubMed ID: 10434439
[TBL] [Abstract][Full Text] [Related]
17. Interstitial brachytherapy and neck dissection for Stage III squamous cell carcinoma of the mobile tongue.
Ihara N; Shibuya H; Yoshimura R; Oota S; Miura M; Watanabe H
Acta Oncol; 2005; 44(7):709-16. PubMed ID: 16227161
[TBL] [Abstract][Full Text] [Related]
18. [An afterloading procedure using 137Cs needle for tongue carcinoma].
Monzen Y; Kiyosue H; Wakisaka M; Maeda T; Mori H; Yanagisawa S
Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Mar; 55(4):263-5. PubMed ID: 7746731
[TBL] [Abstract][Full Text] [Related]
19. Squamous-cell carcinoma of the tongue: preoperative interstitial radium and external irradiation. Part I: Local and regional control.
Vermund H; Brennhovd IO; Kaalhus O; Poppe E
Radiology; 1984 May; 151(2):499-503. PubMed ID: 6424175
[TBL] [Abstract][Full Text] [Related]
20. [Present and future in brachytherapy--from the discovery of radium to the 21st century].
Inoue T; Inoue T
Gan To Kagaku Ryoho; 1999 Aug; 26(9):1254-60. PubMed ID: 10478177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
